T1	AdverseReaction 52 63	Hypotension
T2	AdverseReaction 327 355	Impairment in Renal Function
T3	AdverseReaction 500 512	Hyperkalemia
T4	AdverseReaction 663 675	Hypoglycemia
T5	AdverseReaction 827 853	Genital mycotic infections
T6	AdverseReaction 901 927	Hypersensitivity reactions
T7	AdverseReaction 1010 1023	Bone fracture
T8	AdverseReaction 1117 1132	Increased LDL-C
T9	AdverseReaction 1232 1264	intravascular volume contraction
T10	AdverseReaction 1266 1289	Symptomatic hypotension
T11	AdverseReaction 1958 1984	increases serum creatinine
T12	AdverseReaction 1989 2003	decreases eGFR
T13	AdverseReaction 2073 2101	Renal function abnormalities
T14	Factor 2102 2105	can
T15	AdverseReaction 2333 2345	hyperkalemia
T16	Factor 2321 2324	can
T17	AdverseReaction 2607 2619	hyperkalemia
T18	Factor 2588 2592	risk
T22	AdverseReaction 3091 3103	hypoglycemia
T23	Factor 3083 3087	risk
T24	AdverseReaction 3420 3446	genital mycotic infections
T25	Factor 3412 3416	risk
T26	AdverseReaction 3554 3580	genital mycotic infections
T27	AdverseReaction 3693 3719	Hypersensitivity reactions
T28	AdverseReaction 3727 3748	generalized urticaria
T29	Severity 3756 3763	serious
T30	AdverseReaction 4120 4133	bone fracture
T31	Factor 4112 4116	risk
T32	AdverseReaction 4426 4444	increases in LDL-C
T33	Factor 1290 1293	can
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10 Hypothetical:E34
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13 Hypothetical:E14
E14	Factor:T14
E15	AdverseReaction:T15 Hypothetical:E16
E16	Factor:T16
E17	AdverseReaction:T17 Hypothetical:E18
E18	Factor:T18
E22	AdverseReaction:T22 Hypothetical:E23
E23	Factor:T23
E24	AdverseReaction:T24 Hypothetical:E25
E25	Factor:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27 Effect:E29
E28	AdverseReaction:T28
E29	Severity:T29
E30	AdverseReaction:T27
E31	AdverseReaction:T30 Hypothetical:E32
E32	Factor:T31
E33	AdverseReaction:T32
E34	Factor:T33
A1	CUI E1 C0020649
A2	UMLS-Preferred-Name E1 Hypotension
A3	MEDDRA-PT E1 Hypotension
A4	MEDDRA-PT-ID E1 10021097
A5	CUI E2 C1565489
A6	UMLS-Preferred-Name E2 Renal Insufficiency
A7	MEDDRA-PT E2 Renal impairment
A8	MEDDRA-PT-ID E2 10062237
A9	LLT E2 Impaired renal function
A10	LLT-ID E2 10021523
A11	CUI E3 C0020461
A12	UMLS-Preferred-Name E3 Hyperkalemia
A13	MEDDRA-PT E3 Hyperkalaemia
A14	MEDDRA-PT-ID E3 10020646
A15	LLT E3 Hyperkalemia
A16	LLT-ID E3 10020647
A17	CUI E4 C0020615
A18	UMLS-Preferred-Name E4 Hypoglycemia
A19	MEDDRA-PT E4 Hypoglycaemia
A20	MEDDRA-PT-ID E4 10020993
A21	LLT E4 Hypoglycemia
A22	LLT-ID E4 10021005
A23	CUI E5 C0740330
A24	UMLS-Preferred-Name E5 Genital infection fungal
A25	MEDDRA-PT E5 Genital infection fungal
A26	MEDDRA-PT-ID E5 10061180
A27	CUI E6 C0020517
A28	UMLS-Preferred-Name E6 Hypersensitivity
A29	MEDDRA-PT E6 Hypersensitivity
A30	MEDDRA-PT-ID E6 10020751
A31	LLT E6 Hypersensitivity reaction
A32	LLT-ID E6 10020756
A33	CUI E7 C0016658
A34	UMLS-Preferred-Name E7 Fracture
A35	MEDDRA-PT E7 Fracture
A36	MEDDRA-PT-ID E7 10017076
A37	LLT E7 Fracture bone
A38	LLT-ID E7 10017077
A39	CUI E8 C0549399
A40	UMLS-Preferred-Name E8 Low density lipoprotein increased
A41	MEDDRA-PT E8 Low density lipoprotein increased
A42	MEDDRA-PT-ID E8 10024910
A43	LLT E8 LDL cholesterol increased
A44	LLT-ID E8 10024055
A45	CUI E9 C0750310
A46	UMLS-Preferred-Name E9 Intravascular depletion
A47	MEDDRA-PT E9 Hypovolaemia
A48	MEDDRA-PT-ID E9 10021137
A49	LLT E9 Intravascular depletion
A50	LLT-ID E9 10074191
A51	CUI E10 C0863113
A52	UMLS-Preferred-Name E10 Hypotension symptomatic
A53	MEDDRA-PT E10 Hypotension
A54	MEDDRA-PT-ID E10 10021097
A55	LLT E10 Hypotension symptomatic
A56	LLT-ID E10 10021105
A57	CUI E11 C0700225
A58	UMLS-Preferred-Name E11 Serum creatinine raised
A59	MEDDRA-PT E11 Blood creatinine increased
A60	MEDDRA-PT-ID E11 10005483
A61	LLT E11 Serum creatinine increased
A62	LLT-ID E11 10040233
A63	CUI E12 C0853068
A64	UMLS-Preferred-Name E12 Decreased glomerular filtration rate
A65	MEDDRA-PT E12 Glomerular filtration rate decreased
A66	MEDDRA-PT-ID E12 10018358
A67	LLT E12 GFR decreased
A68	LLT-ID E12 10018214
A69	CUI E13 C0151746
A70	UMLS-Preferred-Name E13 Abnormal renal function
A71	MEDDRA-PT E13 Renal impairment
A72	MEDDRA-PT-ID E13 10062237
A73	LLT E13 Renal function abnormal
A74	LLT-ID E13 10038451
A75	CUI E15 C0020461
A76	UMLS-Preferred-Name E15 Hyperkalemia
A77	MEDDRA-PT E15 Hyperkalaemia
A78	MEDDRA-PT-ID E15 10020646
A79	LLT E15 Hyperkalemia
A80	LLT-ID E15 10020647
A81	CUI E17 C0020461
A82	UMLS-Preferred-Name E17 Hyperkalemia
A83	MEDDRA-PT E17 Hyperkalaemia
A84	MEDDRA-PT-ID E17 10020646
A85	LLT E17 Hyperkalemia
A86	LLT-ID E17 10020647
A87	CUI E22 C0020615
A88	UMLS-Preferred-Name E22 Hypoglycemia
A89	MEDDRA-PT E22 Hypoglycaemia
A90	MEDDRA-PT-ID E22 10020993
A91	LLT E22 Hypoglycemia
A92	LLT-ID E22 10021005
A93	CUI E24 C0740330
A94	UMLS-Preferred-Name E24 Genital infection fungal
A95	MEDDRA-PT E24 Genital infection fungal
A96	MEDDRA-PT-ID E24 10061180
A97	CUI E26 C0740330
A98	UMLS-Preferred-Name E26 Genital infection fungal
A99	MEDDRA-PT E26 Genital infection fungal
A100	MEDDRA-PT-ID E26 10061180
A101	CUI E27 C0020517
A102	UMLS-Preferred-Name E27 Hypersensitivity
A103	MEDDRA-PT E27 Hypersensitivity
A104	MEDDRA-PT-ID E27 10020751
A105	LLT E27 Hypersensitivity reaction
A106	LLT-ID E27 10020756
A107	CUI E28 C0750016
A108	UMLS-Preferred-Name E28 Generalized urticaria
A109	MEDDRA-PT E28 Urticaria
A110	MEDDRA-PT-ID E28 10046735
A111	LLT E28 Generalized urticaria
A112	LLT-ID E28 10049198
A113	CUI E31 C0016658
A114	UMLS-Preferred-Name E31 Fracture
A115	MEDDRA-PT E31 Fracture
A116	MEDDRA-PT-ID E31 10017076
A117	LLT E31 Fracture bone
A118	LLT-ID E31 10017077
A119	CUI E33 C0549399
A120	UMLS-Preferred-Name E33 Low density lipoprotein increased
A121	MEDDRA-PT E33 Low density lipoprotein increased
A122	MEDDRA-PT-ID E33 10024910
A123	LLT E33 LDL cholesterol increased
A124	LLT-ID E33 10024055
